🇺🇸 FDA
Pipeline program

Campylobacter jejuni strain CG8421

CHRMS 10-086

Phase 1 mab active

Quick answer

Campylobacter jejuni strain CG8421 for Campylobacter Infections is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Campylobacter Infections
Phase
Phase 1
Modality
mab
Status
active

Clinical trials